Masato Yoneda

18PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Medical biochemistry - lipidsMetabolic medicineNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Mar 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLD.

Yuya Seko, Taeang Arai, Hirokazu Takahashi

|Aug 03, 2025
Defining optimal fatty liver index thresholds for MASLD and MetALD using controlled attenuation parameter as reference.

Hideki Fujii, Sawako Uchida-Kobayashi, Atsushi Kanamori

|Jun 17, 2025
Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLD.

Masato Yoneda, Yoshio Sumida, Yoshihiro Kamada

|Dec 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease.

Hiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada

|Apr 25, 2024
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.

Kazuhiro Nouso, Miwa Kawanaka, Hideki Fujii

Pageof 3

Frequent Collaborators

9 joint publications

Yoshihiro Kamada

7 joint publications

Hirokazu Takahashi

6 joint publications

Takumi Kawaguchi

5 joint publications

Yoshio Sumida